{{Rsnum
|rsid=2070593
|Gene=GPX3
|Chromosome=5
|position=151028379
|Orientation=plus
|GMAF=0.2902
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=GPX3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 26.5 | 72.6
| HCB | 43.4 | 41.2 | 15.4
| JPT | 25.7 | 58.4 | 15.9
| YRI | 1.4 | 21.8 | 76.9
| ASW | 0.0 | 29.8 | 70.2
| CHB | 43.4 | 41.2 | 15.4
| CHD | 43.1 | 45.0 | 11.9
| GIH | 12.9 | 33.7 | 53.5
| LWK | 0.9 | 31.8 | 67.3
| MEX | 3.4 | 29.3 | 67.2
| MKK | 1.3 | 29.5 | 69.2
| TSI | 4.9 | 26.5 | 68.6
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19375609
|Title=Glutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancer
}}

{{PMID Auto
|PMID=20576521
|Title=Functional glutathione peroxidase 3 polymorphisms associated with increased risk of Taiwanese patients with gastric cancer
}}

{{PMID Auto
|PMID=24278290
|Title=SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}